From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Program Description

The keynote address to PTCE's 2025 Lymphoma Day of Education offers oncology pharmacists a crucial foundation in the evolving pharmacologic landscape of non-Hodgkin lymphoma (NHL) therapies. A thorough understanding of oncology pharmacology is paramount for pharmacists to optimize patient outcomes, mitigate adverse effects, and ensure the safe and effective use of complex therapeutic regimens. Using animation videos, this session will delve into the intricate mechanisms of action and therapeutic targets of novel agents, providing a deeper understanding of how these treatments combat NHL. Attendees will gain essential knowledge to differentiate the unique toxicity profiles, monitoring parameters, and supportive care strategies across various novel therapeutic classes. Furthermore, the address will equip pharmacists with practical insights into agent-specific administration routes, optimal dosing strategies, and critical clinical considerations for seamlessly integrating these innovative NHL therapies into practice.

Target Audience: Oncology Pharmacist

Type of Activity: Application
Release date: September 30, 2025
Expiration date: September 30, 2026
Learner level: Foundational, Intermediate, Advanced
Time to complete activity: 1.25 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

1. Describe the mechanisms of action and therapeutic targets of novel agents used in the treatment of non-Hodgkin lymphoma (NHL)
2. Recognize the unique toxicity profiles, monitoring parameters, and supportive care strategies for novel therapeutic classes used in the treatment of NHL
3. Review agent-specific administration routes, dosing strategies, and clinical considerations for integrating novel NHL therapies

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.25 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-25-313-H01-P. The activity is available for CE credit through September 30, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Samantha Maples, PharmD, BCOP

Consultant; expert panelist for Bristol Myers Squibb

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy L. Morris, PharmD, BCOP; Daphne Davis, PharmD, BCOP; Victoria Chirdo; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with ineligible companies to disclose.

Pharmacy Times® Editorial Staff— Aislinn Antrim

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms